Everolimus,Osimertinib
Actiza,astrazeneca
['specta', 'everest trial', 'tagrisso', 'iressa', 'everest', '$azn']
alpha biopharma's zorifertinib in ph3 everest trial. this was originated by $azn (azd3759), meant as a more cns-penetrant tagrisso, but then divested. comparator is iressa/tarceva however, so not espectally meaningful #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.